XML 28 R9.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Feb. 03, 2024
Jan. 28, 2023
Jan. 29, 2022
Operating activities:      
Net income $ 738,847 $ 891,637 $ 862,473
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization of property and other deferred costs 181,182 190,030 201,435
Deferred income taxes (17,724) (15,299) (7,448)
Gain on disposal of assets (6,053) (21,047) (24,688)
Proceeds from insurance     2,902
Gain from insurance proceeds   (160)  
Loss on early extinguishment of debt     2,830
Accrued interest on short-term investments (5,679) (3,206)  
Changes in operating assets and liabilities:      
Increase in accounts receivable (3,595) (17,175) (3,084)
Decrease (increase) in merchandise inventories 26,209 (40,030) 7,585
Increase in other current assets (7,819) (5,359) (23,769)
Increase in other assets (4,678) (1,161) (3,832)
(Decrease) increase in trade accounts payable and accrued expenses and other liabilities (22,492) (28,582) 122,607
Increase (decrease) in income taxes payable 5,392 (1,257) 143,009
Net cash provided by operating activities 883,590 948,391 1,280,020
Investing activities:      
Purchase of property and equipment and capitalized software (132,944) (120,105) (104,360)
Proceeds from disposal of assets 6,328 25,062 29,296
Proceeds from insurance 4,477 4,886 3,801
Purchase of short-term investments (295,354) (245,696)  
Proceeds from maturities of short-term investments 301,899 100,000  
Distribution from joint venture     1,475
Net cash used in investing activities (115,594) (235,853) (69,788)
Financing activities:      
Principal payments on long-term debt and finance lease liabilities   (44,800) (695)
Cash dividends paid (338,629) (271,313) (305,240)
Purchase of treasury stock (281,411) (452,853) (544,868)
Issuance cost of line of credit     (3,009)
Net cash used in financing activities (620,040) (768,966) (853,812)
Increase (decrease) in cash and cash equivalents and restricted cash 147,956 (56,428) 356,420
Cash and cash equivalents and restricted cash, beginning of period 660,331 716,759 360,339
Cash and cash equivalents and restricted cash, end of period 808,287 660,331 716,759
Non-cash transactions:      
Accrued capital expenditures 6,219 5,155 5,901
Stock awards 4,509 6,186 2,522
Accrued purchases of treasury stock and excise taxes 2,770   16,234
Lease assets obtained in exchange for new operating lease liabilities $ 20,477 $ 3,660 $ 9,627